APG
ABBV icon

Abacus Planning Group’s AbbVie ABBV Stock Holding History

Abacus Planning Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Sell
2,332
-41
-2% -$8.82K 0.07% 132
2026
Q1 		$516K Sell
2,373
-112
-5% -$24.8K 0.07% 138
2025
Q4 		$568K Buy
2,485
+188
+8% +$42.8K 0.08% 119
2025
Q3 		$532K Sell
2,297
-70
-3% -$14.3K 0.07% 122
2025
Q2 		$439K Sell
2,367
-153
-6% -$28.4K 0.07% 138
2025
Q1 		$528K Buy
2,520
+364
+17% +$70.8K 0.09% 110
2024
Q4 		$383K Sell
2,156
-56
-3% -$10.3K 0.07% 137
2024
Q3 		$437K Buy
2,212
+743
+51% +$139K 0.08% 124
2024
Q2 		$252K Buy
1,469
+61
+4% +$10.1K 0.05% 181
2024
Q1 		$256K Sell
1,408
-474
-25% -$81.7K 0.05% 173
2023
Q4 		$292K Buy
+1,882
New +$274K 0.06% 149
2023
Q3 		– Sell
-1,592
Closed -$214K – 190
2023
Q2 		$214K Sell
1,592
-88
-5% -$12.9K 0.05% 178
2023
Q1 		$268K Buy
1,680
+188
+13% +$28.7K 0.07% 144
2022
Q4 		$241K Buy
+1,492
New +$229K 0.07% 152
2022
Q3 		– Sell
-1,764
Closed -$270K – 179
2022
Q2 		$270K Sell
1,764
-197
-10% -$30.1K 0.08% 143
2022
Q1 		$318K Buy
1,961
+302
+18% +$43.9K 0.09% 146
2021
Q4 		$225K Buy
+1,659
New +$196K 0.06% 181

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Abacus Planning Group's ABBV Position: Q2 2026 in Review

Abacus Planning Group reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $8.82K and leaving 2,332 shares worth $587K. The position accounts for 0.07% of the portfolio, ranked #132.

Abacus Planning Group first reported a position in ABBV in Q4 2021 and has held it in 17 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Abacus Planning Group held 2,332 shares of AbbVie worth $587K as of Q2 2026.
  • Abacus Planning Group sold 41 AbbVie shares in Q2 2026, an estimated $8.82K.
  • AbbVie made up 0.07% of Abacus Planning Group's portfolio in Q2 2026, its #132 holding.
  • Abacus Planning Group first reported a position in AbbVie in Q4 2021 and has held it in 17 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.